PCC Rokita SA (WSE:PCR)

Market Cap	1.30B -3.3%
Revenue (ttm)	1.72B -12.2%
Net Income	53.06M -59.0%
EPS	2.66 -59.3%
Shares Out	20.26M
PE Ratio	24.10
Forward PE	10.70
Dividend	2.65 (4.14%)
Ex-Dividend Date	Apr 24, 2026

Volume	15,499
Open	63.70
Previous Close	63.00
Day's Range	63.60 - 64.80
52-Week Range	58.40 - 74.40
Beta	0.60
Analysts	Strong Buy
Price Target	82.41 (+28.77%)
Earnings Date	Aug 19, 2026

About PCC Rokita

PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy, and Other Activities. The Polyurethanes segment produces polyols, polyurethane systems, and prepolymers; and flexible foams, rigid foams, coatings, elastomers, adhesives, impregnations, and other products. The Chlorine Derivatives segment provides chlorine, sodium hydroxide, caus...

• Industry: Chemicals
• Sector: Materials
• Founded: 2002
• Employees: 1,649
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PCR

Financial Performance

In 2025, PCC Rokita's revenue was 1.80 billion, a decrease of -7.50% compared to the previous year's 1.95 billion. Earnings were 61.48 million, a decrease of -57.02%.

Analyst Summary

According to 2 analysts, the average rating for PCR stock is "Strong Buy." The 12-month stock price target is zł 82.41, which is an increase of 28.77% from the latest price.

Price Target

zł 82.41

(28.77% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error